BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM
148 results:

  • 1. Clinical and Biologic Correlates of ADORA2A Transcriptomic Expression in Cancer.
    Shreenivas A; Nishizaki D; Lee S; Pabla S; Nesline M; Conroy JM; DePietro P; Kato S; Kurzrock R
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731962
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. LncRNA CHKB-DT Downregulation Enhances Dilated Cardiomyopathy Through aldh2.
    Nie X; Fan J; Dai B; Wen Z; Li H; Chen C; Wang DW
    Circ Res; 2024 Feb; 134(4):425-441. PubMed ID: 38299365
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
    Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
    Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Discovery of potent thiazolidin-4-one sulfone derivatives for inhibition of proliferation of osteosarcoma in vitro and in vivo.
    Chen X; Luo Z; Hu Z; Sun D; He Y; Lu J; Chen L; Liu S
    Eur J Med Chem; 2024 Feb; 266():116082. PubMed ID: 38232462
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. sarcomas Harboring EWSR1::PATZ1 Fusions: A Clinicopathologic Study of 17 Cases.
    Dehner CA; Torres-Mora J; Gupta S; Kipp BR; Halling KC; Chen S; Warmke LM; Michal M; Alani A; Yu W; Kovacs K; Obeidin F; Iwenofu OH; Satturwar S; Meis JM; Folpe AL
    Mod Pathol; 2024 Feb; 37(2):100400. PubMed ID: 38043789
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Isolated vaginal recurrence in women with stage I endometrial cancer.
    Rios-Doria E; Cun HT; Filippova OT; Mueller JJ; Alektiar KM; Ellenson LH; Makker V; Lakhman Y; Leitao MM; Jhingran A; Soliman PT; Abu-Rustum NR
    Gynecol Oncol; 2023 Dec; 179():9-15. PubMed ID: 37864854
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
    Pant S; Schuler M; Iyer G; Witt O; Doi T; Qin S; Tabernero J; Reardon DA; Massard C; Minchom A; Lugowska I; Carranza O; Arnold D; Gutierrez M; Winter H; Stuyckens K; Crow L; Najmi S; Hammond C; Thomas S; Santiago-Walker A; Triantos S; Sweiti H; Loriot Y;
    Lancet Oncol; 2023 Aug; 24(8):925-935. PubMed ID: 37541273
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identifying novel therapeutic inhibitors to target FMS-like tyrosine kinase-3 (FLT3) against acute myeloid leukemia: a molecular docking, molecular dynamics, and DFT study.
    Islam MR; Osman OI; Hassan WMI
    J Biomol Struct Dyn; 2024; 42(1):82-100. PubMed ID: 36995071
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent.
    Dapper H; Diehl C; Knebel C; Mogler C; Borm K; Dobiasch S; Combs SE; Peeken JC
    Radiat Oncol; 2023 Mar; 18(1):44. PubMed ID: 36869396
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic Significance of Percentage and Size of Dedifferentiation in Dedifferentiated Chondrosarcoma.
    Hung YP; Chebib I; Bredella MA; Berner EA; Taylor-Black Q; Choy E; Cote GM; Chen YL; MacDonald SM; Schwab JH; Raskin KA; Newman ET; Selig MK; Deshpande V; Hornick JL; Lozano-Calderón SA; Nielsen GP
    Mod Pathol; 2023 Mar; 36(3):100069. PubMed ID: 36788104
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cyclopropenone, Cyclopropeniminium Ion, and Cyclopropenethione as Novel Electrophilic Warheads for Potential Target Discovery of Triple-Negative Breast Cancer.
    Lv S; Xu F; Fan Y; Ding K; Li Z
    J Med Chem; 2023 Feb; 66(4):2851-2864. PubMed ID: 36762554
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Successful first-line treatment of simultaneous multiple primary malignancies of lung adenocarcinoma and renal clear cell carcinoma: A case report.
    Ye X; Liu X; Yin N; Song W; Lu J; Yang Y; Chen X
    Front Immunol; 2022; 13():956519. PubMed ID: 35979370
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Local Control Outcomes Using Stereotactic Body Radiation Therapy or Surgical Resection for Metastatic Sarcoma.
    Gutkin PM; von Eyben R; Chin A; Donaldson SS; Oh J; Jiang A; Ganjoo KN; Avedian RS; Bruzoni M; Steffner RJ; Moding EJ; Hiniker SM
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):771-779. PubMed ID: 35643255
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma.
    Mo C; Wu Y; Ma J; Xie L; Huang Y; Xu Y; Peng H; Chen Z; Zeng M; Mao R
    BMC Med Genomics; 2022 Apr; 15(1):81. PubMed ID: 35410253
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comorbidity, body mass index, and performance status as prognostic factors in older patients with soft-tissue sarcoma.
    Tamiya H; Imura Y; Wakamatsu T; Takenaka S
    J Geriatr Oncol; 2022 Jun; 13(5):673-681. PubMed ID: 35219635
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases.
    Kamitani R; Matsumoto K; Takeda T; Mizuno R; Oya M
    BMC Cancer; 2022 Jan; 22(1):15. PubMed ID: 34980039
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pleomorphic dermal sarcoma: Clinicopathological features and outcomes from a 5-year tertiary referral centre experience.
    Logan IT; Vroobel KM; le Grange F; Perrett CM
    Cancer Rep (Hoboken); 2022 Nov; 5(11):e1583. PubMed ID: 34766474
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data.
    Jing W; Lan T; Qiu Y; Peng R; Lu Y; Chen H; Chen M; He X; Chen C; Zhang H
    Diagn Pathol; 2021 Oct; 16(1):96. PubMed ID: 34696768
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients.
    Diaz Coronado RY; Mynarek M; Koelsche C; Mora Alferez P; Casavilca Zambrano S; Wachtel Aptowitzer A; Sahm F; von Deimling A; Schüller U; Spohn M; Sturm D; Pfister SM; Morales La Madrid A; Sernaque Quintana R; Sarria Bardales G; Negreiros Chinchihuara T; Ojeda Medina L; Garcia-Corrochano Medina P; Campos Sanchez DA; Ponce Farfan J; Rutkowski S; Garcia Leon JL
    Cancer; 2022 Feb; 128(4):697-707. PubMed ID: 34674226
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Variation in Management of Extremity Soft-Tissue Sarcoma in Younger vs Older Adults.
    Seldon C; Shrivastava G; Al-Awady A; Asher D; Ramey S; Fernandez M; Dooley S; Kwon D; Zhao W; Goel N; Diwanji T; Subhawong T; Trent J; Yechieli R
    JAMA Netw Open; 2021 Aug; 4(8):e2120951. PubMed ID: 34415314
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.